We analyzed coded CKD prevalence and incidence, non-recommended drug prescriptions (dual prescriptions of angiotensin-converting enzyme inhibitors with angiotensin II receptor blockers; non-steroidal anti-inflammatory drugs in CKD stage 4–5), as well as albumin/creatinine ratio (ACR) and dipstick testing in incident CKD cases. Here, ACE is linked to chronic kidney disease.